Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 4 The effect of pravastatin (Prava) and mevalonate (MEV) on the production and messenger ribonucleic acid (mRNA) levels of transforming growth factor-beta1 (TGF-beta1). (A) Bioassay of TGF-beta1 activity in a conditioned medium of monocyte cultures incubated with pravastatin (1–10 µM) or pravastatin (5 µM) plus mevalonate (100 µM). A conditioned medium from the cultures was collected after 24 h and acidified for mink-lung epithelial cell bioassay. Mink-lung cells respond to TGF-beta1 released in the culture medium, with a dose-dependent decrease in deoxyribonucleic acid (DNA) synthesis, as evaluated by 3H-thymidine incorporation. A comparison with the standard curve and multiplication by the dilution factor (1:10) yielded a dose-dependent increase in the TGF-beta1 concentration (ng/ml) in the conditioned medium of monocyte cultures. Mevalonate reversed the TGF-beta1–dependent effect on mink-lung cells. The results are expressed as the mean value ± SD of three independent experiments performed in triplicate. Comparisons among treatment conditions were carried out by analysis of variance, followed by Dunnett’s test. *p < 0.05, **p < 0.01 and p = NS versus untreated (control) cells. (B) Representative Northern blot analysis of TGF-beta1 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA in human peripheral blood monocytes after incubation with pravastatin (5 µM) alone or mevalonate (100 µM) together with pravastatin (5 µM). Mononuclear cells were cultured 24 h in serum-free conditions. Total RNA (5 µg per lane) was electrophoresed on 1.5% formaldehyde agarose gels, transferred to nitrocellulose and hybridized with 32P random primer-labeled TGF-beta1 complementary DNA. The sizes of the transcripts were determined by comparison with 28S and 18S ribosomal RNA. Molecular size markers are shown on the left. Lane 1 = untreated cells; lane 2 = pravastatin-treated cells; and lane 3 = cell treated with pravastatin plus mevalonate. Quantitative data obtained from imaging are expressed in arbitrary units.





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement